Kathleen Marie Douglas, | |
145 School St., Rochester, VT 05767-0184 | |
(802) 767-3332 | |
Not Available |
Full Name | Kathleen Marie Douglas |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Adult Health |
Location | 145 School St., Rochester, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215115886 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WE0003X | Registered Nurse - Emergency | R083751 (Maryland) | Secondary |
363LA2200X | Nurse Practitioner - Adult Health | R083751 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kathleen Marie Douglas, 145 School St., Rochester, VT 05767-0184 Ph: (802) 767-3332 | Kathleen Marie Douglas, 145 School St., Rochester, VT 05767-0184 Ph: (802) 767-3332 |
News Archive
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "Preventive health care is important at any age, but never more so than as we get older.
With a House vote scheduled for Thursday, the White House is on record opposing the "offset" used to pay for the repeal of this reporting provision included in the health law, but it also stopped short of threatening a veto. This part of the bill also may cause it to lose bipartisan support in the lower chamber.
Six universities have agreed to an effort to "encourage companies to give poor countries better access to drugs and medical products stemming from discoveries made on their campuses," Bloomberg reports (Lauerman, 11/9).
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
› Verified 4 days ago